glp-1 novo Novo, Lilly buoyed by fast-growing drug sales GLP-1 RA education

PubMed One real-world study showed that patients with type 2 diabetes using GLP-1 RAs had a reduced risk of incident dementia compared with some other second-line diabetes therapies

For example, a patient beginning their GLP-1 therapy might start with a lower dose to minimize potential side effects such as gastrointestinal discomfort, and then gradually increase the dosage as their body adjusts, thereby aligning with their weight loss objectives and overall health goals

Later medications like semaglutide and tirzepatide are engineered versions - chemically modified human GLP-1 with structural changes that prevent degradation and extend half-life from seconds to days

Several participants reported improvements in self-esteem, self-confidence and body image, which was not always explained by weight loss, as similar changes in confidence had not been experienced in previously successfully weight loss methods